Harmony Biosciences director granted 21,872 stock options
Harmony Biosciences Holdings, Inc. director Gary Sender reported a grant of stock options covering 21,872 shares of common stock.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Form Type
4
Rhea-AI Filing Summary
Harmony Biosciences Holdings, Inc. director Gary Sender reported a grant of stock options covering 21,872 shares of common stock. The options have an exercise price of $30.76 per share and expire on May 14, 2036. They vest in full on the earlier of May 14, 2027 or the next annual meeting following the grant date, subject to continued service. This is a compensation-related award rather than an open-market trade.
Insider Trade Summary
Grant/Award: 21,872 shares
Grant/Award
1 txn
Insider
Sender Gary
Role
Director
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Stock Option | 21,872 | $0.00 | $0.00 |
Holdings After Transaction:
Stock Option — 21,872 contracts (Direct)
Footnotes (1)
- F1. The stock option shall vest in full on the earlier to occur of (i) May 14, 2027 and (ii) the date of the next annual meeting following the grant date, subject to continued service through the applicable vesting date.
Key Figures
Stock options granted: 21,872 options
Exercise price: $30.76 per share
Expiration date: May 14, 2036
+1 more
4 metrics
Stock options granted
21,872 options
Grant to director Gary Sender
Exercise price
$30.76 per share
Strike price of stock option grant
Expiration date
May 14, 2036
Option term end
Shares underlying options
21,872 shares
Common stock underlying granted options
Key Terms
Stock Option, exercise price, expiration date, Form 4, +1 more
5 terms
Stock Option financial
"security_title: "Stock Option" with underlying common stock"
A stock option is a contract that gives you the right to buy or sell a company's stock at a specific price within a certain time frame. People use them to potentially make money if the stock's price moves favorably or to protect against losses. It's like holding a coupon that can be used to buy or sell stock at a set price later on.
exercise price financial
"conversion_or_exercise_price of 30.7600 per share"
The exercise price is the fixed amount at which you can buy or sell an asset, like a stock, when using an options contract. It matters because it helps determine whether exercising the option will be profitable or not, depending on the current market price. Think of it as the set price you agree on today to buy or sell later.
expiration date financial
"expiration_date set to 2036-05-14T00:00:00.000Z"
The expiration date is the deadline after which a financial contract, such as an option or a futures agreement, is no longer valid or can be exercised. It matters to investors because it determines the timeframe during which they can take action or benefit from the contract, similar to how a coupon or a food item has a limited period of usefulness. Once the expiration date passes, the contract loses its value or ability to be used.
Form 4 regulatory
"INSIDER FILING DATA (Form 4) for Harmony Biosciences"
Form 4 is a official document that company insiders, such as executives or major shareholders, file with regulators whenever they buy or sell company shares. It provides transparency about how those with inside knowledge are trading, helping investors see if insiders are confident in the company's prospects or may be selling for personal reasons. This information can influence investor decisions by revealing insiders' perspectives on the company's value.
vest in full financial
"The stock option shall vest in full on the earlier to occur of (i) May 14, 2027"
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What insider transaction did Harmony Biosciences (HRMY) director Gary Sender report?
Gary Sender reported receiving a stock option grant for 21,872 shares of Harmony Biosciences common stock. The award is a compensation-related grant, not an open-market trade, and gives him the right to buy shares at a fixed exercise price if it vests.
What is the exercise price of Gary Sender’s new Harmony Biosciences (HRMY) stock options?
The stock options granted to Gary Sender have an exercise price of $30.76 per share. This means he can purchase Harmony Biosciences common stock at $30.76 if the options vest and he chooses to exercise them before they expire.
When do Gary Sender’s Harmony Biosciences (HRMY) stock options vest?
Gary Sender’s stock options vest in full on the earlier of May 14, 2027, or the date of the next annual meeting after the grant. Vesting is conditional on his continued service with Harmony Biosciences through the applicable vesting date.
When do Gary Sender’s Harmony Biosciences (HRMY) stock options expire?
The stock options granted to Gary Sender expire on May 14, 2036. If he does not exercise them by that expiration date, the right to purchase Harmony Biosciences shares at the $30.76 exercise price will lapse and become worthless.
Is Gary Sender’s Harmony Biosciences (HRMY) Form 4 transaction a stock purchase or sale?
The Form 4 transaction reflects a grant of stock options, not a purchase or sale of shares in the open market. It is a compensation-related award giving him potential future rights to acquire Harmony Biosciences common stock.
AI-generated analysis. How Rhea-AI works. Not financial advice.
Accepted by SEC EDGAR
Learn about SEC filing dates